Cellectis S.A. ADR (CLLS)

$15.18 0.12 (0.78%)
16:00 EDT CLLS Stock Quote Delayed 30 Minutes

Investing in CRISPR Stocks: Ultimate Genetic Editing Guide

The biotech space is on the verge of hypergrowth, thanks to a scientific breakthrough in genetic editing. This is your ultimate guide to understanding and profiting from CRISPR stocks.

7 CRISPR Stocks for the Future of Medicine

5 Great Biotech Stocks to Buy Now (CLLS, CELG, EXAS, EXEL, SNSS)

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 649.40M
PE Ratio -
Volume (Avg. Vol.) 183,396
Day's Range 15.05 - 15.49
52-Week Range 14.18 - 34.71
Dividend & Yield N/A (N/A)